Mental Health Utilization Increased Around Time of Prostate Cancer Diagnosis
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 16, 2024 -- There is an increase in psychotropic medication use and mental health service use around the time of prostate cancer diagnosis, according to a study published online July 3 in Psycho-Oncology.
Tenaw Tiruye, Ph.D., from the University of South Australia in Adelaide, and colleagues used registry data linked to Pharmaceutical Benefits Scheme and Medicare Benefits Schedule data for 13,693 prostate cancer patients diagnosed between 2012 and 2020 to estimate the proportion and rates of psychotropic medication and mental health service use before and after diagnosis.
The researchers found that 15 percent of men started psychotropic medications and 6.4 percent sought out mental health services for the first time after diagnosis. From five years before to five years after diagnosis, psychotropic medication use rose from 34.5 to 40.3 percent, including an increase in use of antidepressants (from 20.7 to 26.0 percent) and anxiolytics (from 11.3 to 12.8 percent). The mental health service use increase (from 10.2 to 12.1 percent) occurred mostly from general practice mental health visits (from 7.8 to 10.6 percent). A significant rise in medication and service utilization immediately before and in the first two years following prostate cancer diagnosis was revealed in interrupted time series analyses.
"Mental health outcomes of men with prostate cancer may be improved with early mental health screening, particularly during the diagnosis process, to enable early intervention," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease
MONDAY, July 14, 2025 -- Men with nonmetastatic prostate cancer receiving guideline-concordant care have a much higher risk for death from causes other than prostate cancer...
Adding Anxiety as Qualifier for Medical Cannabis Increases Number of Certifications
FRIDAY, July 11, 2025 -- Adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications, according to a...
Loneliness Is Predictor of Depression, Poor Health Outcomes
THURSDAY, July 10, 2025 -- Loneliness is a predictor of depression and poor health outcomes, according to a study published online July 9 in PLOS ONE. Oluwasegun Akinyemi, M.D...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.